The Special Medical Physics Consult Process for Reirradiation Patients

• Published in: Advances in radiation oncology 2019-10, Vol.4 (4), p.559-565
• Main Authors: Paradis, Kelly C., PhD, Mayo, Charles, PhD, Owen, Dawn, MD, Spratt, Daniel E., MD, Hearn, Jason, MD, Rosen, Benjamin, PhD, Kashani, Rojano, PhD, Moran, Jean, PhD, Tatro, Daniel S., CMD, Beeler, Whitney, MD, Vineberg, Karen, CMD, Smith, Dylan C., MS, Matuszak, Martha M., PhD
• Format: Article
• Language: English
• Subjects: Hematology, Oncology, and Palliative Medicine; Special Collection: The Advancing Practice of Re-irradiation in Radiation Oncology: Challenges, Outcomes and Approach
• ISSN: 2452-1094; 2452-1094
• DOI: 10.1016/j.adro.2019.05.007

AbstractPurposeTo present a systematic approach to the reirradiation special medical physics consult (ReRT-SMPC) process.Materials and MethodsAn in-house reirradiation committee of physicians and physicists was formed to develop a streamlined and well-documented approach to ReRT-SMPCs. Dosimetric goals and considerations for tissue repair were generated by the committee with input from the literature, clinical trial guidelines, and physician experience. Procedural workflow was also defined.ResultsThe total number of ReRT-SMPCs performed in our department in 2018 was 401, corresponding to 369 unique patients and 16% of the total number of patients receiving external beam radiation in our department that year. This constituted a large increase over the 183 ReRT-SMPCs performed in 2017. We have found that a standardized ReRT-SMPC workflow helps to safeguard patients, documents the clinical decision-making process for medical and legal purposes, and facilitates the peer-review process. The data being collected from each consult along with toxicity and outcomes data can be used to help inform future re-treatment guidelines.ConclusionsAs the number of patients returning for additional courses of radiation continues to increase, a uniform method for the ReRT-SMPC workflow and analysis is a powerful tool for ensuring patient safety, understanding and predicting treatment toxicity, and refining reirradiation dosimetric limits.